B

BioDelivery Sciences International Inc
F:BD5

Watchlist Manager
BioDelivery Sciences International Inc
F:BD5
Watchlist
Price: 5.05 EUR Market Closed
Market Cap: 521.3m EUR

Intrinsic Value

BD5 price has not been updated for more than 10 months. This may indicate that the stock has been delisted.

There is not enough data to reliably calculate the intrinsic value of BD5.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BD5 Intrinsic Value
Not Available
B
Base Case Scenario
Compare BD5 to

Fundamental Analysis

BioDelivery Sciences International Inc
F:BD5
US
Pharmaceuticals
Market Cap
499.2m EUR
IPO
Jun 25, 2002
US
Pharmaceuticals
Market Cap
499.2m EUR
IPO
Jun 25, 2002
Price
€
$
BioDelivery Sciences International Inc
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BD5?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
BioDelivery Sciences International Inc

Current Assets 202.1m
Cash & Short-Term Investments 114.3m
Receivables 56.9m
Other Current Assets 30.9m
Non-Current Assets 122.5m
PP&E 1.7m
Intangibles 61.5m
Other Non-Current Assets 59.2m
Current Liabilities 82.4m
Accounts Payable 8.1m
Accrued Liabilities 69m
Other Current Liabilities 5.3m
Non-Current Liabilities 54.4m
Long-Term Debt 54.2m
Other Non-Current Liabilities 219k
Efficiency

Free Cash Flow Analysis
BioDelivery Sciences International Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
BioDelivery Sciences International Inc

Revenue
166.7m USD
Cost of Revenue
-23.4m USD
Gross Profit
143.3m USD
Operating Expenses
-106.2m USD
Operating Income
37.1m USD
Other Expenses
47.7m USD
Net Income
84.9m USD
Fundamental Scores

BD5 Profitability Score
Profitability Due Diligence

BioDelivery Sciences International Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Exceptional ROIC
Exceptional ROE
Exceptional Net Margin
Exceptional Gross Margin
59/100
Profitability
Score

BioDelivery Sciences International Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

BD5 Solvency Score
Solvency Due Diligence

BioDelivery Sciences International Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Negative Net Debt
Long-Term Solvency
51/100
Solvency
Score

BioDelivery Sciences International Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BD5 Price Targets Summary
BioDelivery Sciences International Inc

There are no price targets for BD5.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BD5 is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y